One of the most vibrant areas of HIV research these days is the search for new, more convenient ways to use antiretroviral medicines (ARVs) to prevent HIV infection. Elri Voigt rounds up the HIV pre-exposure prophylaxis (PrEP) research presented at the recent International AIDS Society Conference, including a biodegradable antiretroviral implant.
According to the National Department of Health HIV prevention pills are now available at 1 227 public sector facilities (36% of the total). While far from the 100% target, this is a substantial improvement on the roughly 160 facilities that provided the pills six months ago. Amy Green reports.
A recent announcement about a vaginal ring to prevent HIV has AIDS activists and women’s sexual and reproductive health advocates excited. But where would this ring fit in South Africa’s HIV prevention programme? Amy Green investigates.